 Shares of Digirad NASDAQ:DRAD fell 5.6 in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share fell 175.00 over the past year to 0.11, which may not compare to the estimate of 1.42.Revenue of 22,342,000 declined by 13.40 year over year, which beat the estimate of 9,050,000.Looking Ahead Digirad hasnt issued any earnings guidance for the time being.Revenue guidance hasnt been issued by the company for now.How To Listen To The Conference Call Date: Aug 13, 2020View more earnings on DRADTime: 11:00 AMET Webcast URL: Action Companys 52-week high was at 8.84Companys 52-week low was at 1.99Price action over last quarter: Up 29.80Company Profile Digirad Corp is a United States-based company which delivers healthcare solutions. The diverse portfolio of healthcare solutions of the company includes mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring. The company provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. The company operates through three reportable segments namely Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. It generates a majority of its revenue from the Diagnostic Services followed by Mobile Healthcare segment.See more from Benzinga Earnings Scheduled For August 13, 2020C 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 